Penny Stock News Revive Therapeutics Announces Filing of a Pre-CTA Meeting Request with Health Canada and Update on U.S. FDA IND Filing and Phase 3 Clinical Trial Design for Bucillamine in the Treatment of COVID-19 TORONTO, June 03, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or… June 3, 20205 minute read
Biotech Stocks Defining The Next Generation Of Coronavirus Stocks: This Company Comes into Focus Revive Therapeutics Ltd. (OTC: RVVTF) (CSE: RVV): Management Believes That The Company… May 17, 20209 minute read
Penny Stock News Revive Therapeutics Provides Corporate Update on its Pharmaceutical Initiatives TORONTO, May 13, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or… May 13, 20205 minute read
